Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transcriptional heterogeneity predicts and enables clonal selection in ageing haematopoiesis.

Research square·2026

Same author

In vivo reduction of Treg expansion in rodent helminth-malaria coinfection.

Parasites & vectors·2026

Same author

Ploidy shapes gemcitabine response through altered potency and delayed cell death.

bioRxiv : the preprint server for biology·2026

Same author

The cost of fame for popular species: strong risk of biases in comparative oncology of captive species.

Proceedings. Biological sciences·2026

Same author

Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLC.

bioRxiv : the preprint server for biology·2026

Same author

Repurposing Artesunate to Combat Progression and Metastasis via Targeting Circulating Tumor Cells.

Oncology research·2026

Same journal

Non-canonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy.

eLife·2026

Same journal

Analysis of dendritic input currents during place field dynamics.

eLife·2026

Same journal

TopoMetry systematically learns and evaluates the latent geometry of single-cell data.

eLife·2026

Same journal

Navigating the path: Advice to physician-scientists on choosing a clinical specialty.

eLife·2026

Same journal

Neural activity profiles reveal overlapping, intermingled subpopulations spanning area borders in mouse sensorimotor cortex.

eLife·2026

Same journal

The exquisite mechanics of a tsetse bite.

eLife·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 11, 2025

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Group phenotypic composition in cancer.

Jean-Pascal Capp¹, James DeGregori², Aurora M Nedelcu³

¹Toulouse Biotechnology Institute, University of Toulouse, INSA, CNRS, INRAE, Toulouse, France.

|March 30, 2021

Summary

This summary is machine-generated.

Cancer cells function as groups, not just individuals. Understanding group phenotypic composition (GPC) is key to cancer evolution and developing new therapies.

Keywords:

cancer biology ecology evolutionary biology medicine

More Related Videos

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

Related Experiment Videos

Last Updated: Nov 11, 2025

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

Area of Science:

Evolutionary biology
Cancer research
Cellular cooperation

Background:

Individual cancer cells are often viewed as the primary units of selection in tumors.
Reductionist approaches struggle to explain complex tumor behaviors like angiogenesis and immune evasion.
These collective actions require coordinated group behavior, not just individual cell capabilities.

Purpose of the Study:

To challenge the solely individualistic view of cancer cell evolution.
To introduce and define the concept of group phenotypic composition (GPC).
To highlight the importance of GPC in understanding cancer progression and therapeutic strategies.

Main Methods:

Review of existing studies on collective cell behavior in cancer.
Conceptual framework development for group phenotypic composition (GPC).
Illustrative examples of GPC in cancer biology.

Main Results:

Tumor progression involves group-level phenomena (e.g., angiogenesis, immune suppression) that single cells cannot achieve.
The success of group activities depends on the diverse phenotypes within the cell group.
Group activities influence individual cell fitness and alter the overall group composition.

Conclusions:

The concept of group phenotypic composition (GPC) offers a novel framework for cancer research.
Considering GPC can provide new insights into cancer evolution and clinical behavior.
The GPC framework may guide the development of innovative cancer therapeutic strategies.